Literature DB >> 25454304

Diagnosis and management of hereditary hemochromatosis.

Reena J Salgia1, Kimberly Brown2.   

Abstract

Hereditary hemochromatosis is a rare genetic disorder that can have significant clinical consequences. Hemochromatosis is associated with iron overload, and can initially be recognized through laboratory testing for serum ferritin and transferrin saturation. Genetic testing for the HFE mutation can be performed in patients with elevated iron indices and a suspicion for hemochromatosis or liver disease. The main pathway resulting in iron overload is through altered hepcidin levels. Treatment of patients with the clinical phenotype of hereditary hemochromatosis is commonly through phlebotomy for removal of excess iron stores. This article highlights the current information and data regarding the diagnosis and management of hemochromatosis.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cirrhosis; Ferritin; Hemochromatosis; Iron saturation; Liver transplant

Mesh:

Substances:

Year:  2014        PMID: 25454304     DOI: 10.1016/j.cld.2014.09.011

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  15 in total

Review 1.  Impact of etiological treatment on prognosis.

Authors:  Chien-Wei Su; Ying-Ying Yang; Han-Chieh Lin
Journal:  Hepatol Int       Date:  2017-07-12       Impact factor: 6.047

2.  MRI-based R2* mapping in patients with suspected or known iron overload.

Authors:  Emre Aslan; Jack W Luo; An Lesage; Philippe Paquin; Milena Cerny; Anne Shu-Lei Chin; Damien Olivié; Guillaume Gilbert; Denis Soulières; An Tang
Journal:  Abdom Radiol (NY)       Date:  2021-01-02

3.  Extrahepatic deficiency of transferrin receptor 2 is associated with increased erythropoiesis independent of iron overload.

Authors:  Aaron M Wortham; Devorah C Goldman; Juxing Chen; William H Fleming; An-Sheng Zhang; Caroline A Enns
Journal:  J Biol Chem       Date:  2020-02-13       Impact factor: 5.157

Review 4.  Iron homeostasis: a new job for macrophages in adipose tissue?

Authors:  Merla J Hubler; Kristin R Peterson; Alyssa H Hasty
Journal:  Trends Endocrinol Metab       Date:  2015-01-16       Impact factor: 12.015

Review 5.  Hepcidin: A Promising Therapeutic Target for Iron Disorders: A Systematic Review.

Authors:  Jing Liu; Bingbing Sun; Huijun Yin; Sijin Liu
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

Review 6.  A Review on Iron Chelators in Treatment of Iron Overload Syndromes.

Authors:  Naser Mobarra; Mehrnoosh Shanaki; Hassan Ehteram; Hajar Nasiri; Mehdi Sahmani; Mohsen Saeidi; Mehdi Goudarzi; Hoda Pourkarim; Mehdi Azad
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2016-10-01

7.  A case report of hereditary hemochromatosis caused by mutation of SLC40A1 gene.

Authors:  Xin Yin; Yu Zhang; Hui Gao; Qing-Long Jin; Xiao-Yu Wen
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

8.  Insights into an Optimization of Plasmodium vivax Sal-1 In Vitro Culture: The Aotus Primate Model.

Authors:  Kathryn Shaw-Saliba; Richard Thomson-Luque; Nicanor Obaldía; Marlon Nuñez; Sahir Dutary; Caeul Lim; Samantha Barnes; Clemens H M Kocken; Manoj T Duraisingh; John H Adams; Erica M Pasini
Journal:  PLoS Negl Trop Dis       Date:  2016-07-27

Review 9.  Limitations of Serum Ferritin in Diagnosing Iron Deficiency in Inflammatory Conditions.

Authors:  Axel Dignass; Karima Farrag; Jürgen Stein
Journal:  Int J Chronic Dis       Date:  2018-03-18

10.  Evaluation of a screening program for iron overload and HFE mutations in 50,493 blood donors.

Authors:  Carl Eckerström; Sofia Frändberg; Lena Lyxe; Cecilia Pardi; Jan Konar
Journal:  Ann Hematol       Date:  2020-08-26       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.